SVB Wealth’s Acer Therapeutics Inc ACER Stock Holding History

SVB Wealth’s Portfolio ACER Stock Details ACER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,500	Closed	-$28.9K	–	1090
2022 Q4	$28.9K	Buy	+11,500	New	+$19.7K	﹤0.01%	1026

Other funds holding ACER

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MWM

Meridian Wealth Management Lexington, Kentucky $2.85B AUM 31.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SVB Wealth's ACER Position: Q1 2023 in Review

SVB Wealth sold out of Acer Therapeutics Inc (ACER) in Q1 2023, closing a stake of 11,500 shares — an estimated $28.9K sold.

SVB Wealth first reported a position in ACER in Q4 2022 and held it in 1 quarter. The position peaked at $28.9K in Q4 2022. 27 funds tracked by Wall St. Rank hold ACER as of Q1 2023.

SVB Wealth reported no remaining Acer Therapeutics Inc position as of Q1 2023 after selling out during the quarter.
SVB Wealth sold 11,500 Acer Therapeutics Inc shares in Q1 2023, an estimated $28.9K.
SVB Wealth first reported a position in Acer Therapeutics Inc in Q4 2022 and held it in 1 quarter.
SVB Wealth's Acer Therapeutics Inc position peaked at $28.9K in Q4 2022.
27 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q1 2023.

Based on SVB Wealth's 13F filing for Q1 2023, filed 12 May 2023.